Cite

HARVARD Citation

    Shahzad, M. et al. (2023). Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review. Leukemia & lymphoma. 64 (2), pp. 273-282. [Online]. 
  
Back to record